Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

ViewpointIn-Press Preview Free access | 10.1172/JCI148832

SARS-Cov2 variants and convalescent plasma: reality, fallacies, and opportunities

Arturo Casadevall,1 Jeffrey Henderson,2 Michael Joyner,3 and Liise-anne Pirofski4

1Department of Molecular Microbiology and Immunology, Johns Hopkins School of Public Health, Baltimore, United States of America

2Department of Medicine and Molecular Microbiology, Washington University in St. Louis School of Medicine, St. Louis, United States of America

3Department of Anesthesiology and Periopertive Medicine, Mayo Clinic, Rochester, United States of America

4Departments of Medicine, Microbiology and Immunology, Albert Einstein College of Medicine, New York, United States of America

Find articles by Casadevall, A. in: JCI | PubMed | Google Scholar |

1Department of Molecular Microbiology and Immunology, Johns Hopkins School of Public Health, Baltimore, United States of America

2Department of Medicine and Molecular Microbiology, Washington University in St. Louis School of Medicine, St. Louis, United States of America

3Department of Anesthesiology and Periopertive Medicine, Mayo Clinic, Rochester, United States of America

4Departments of Medicine, Microbiology and Immunology, Albert Einstein College of Medicine, New York, United States of America

Find articles by Henderson, J. in: JCI | PubMed | Google Scholar |

1Department of Molecular Microbiology and Immunology, Johns Hopkins School of Public Health, Baltimore, United States of America

2Department of Medicine and Molecular Microbiology, Washington University in St. Louis School of Medicine, St. Louis, United States of America

3Department of Anesthesiology and Periopertive Medicine, Mayo Clinic, Rochester, United States of America

4Departments of Medicine, Microbiology and Immunology, Albert Einstein College of Medicine, New York, United States of America

Find articles by Joyner, M. in: JCI | PubMed | Google Scholar

1Department of Molecular Microbiology and Immunology, Johns Hopkins School of Public Health, Baltimore, United States of America

2Department of Medicine and Molecular Microbiology, Washington University in St. Louis School of Medicine, St. Louis, United States of America

3Department of Anesthesiology and Periopertive Medicine, Mayo Clinic, Rochester, United States of America

4Departments of Medicine, Microbiology and Immunology, Albert Einstein College of Medicine, New York, United States of America

Find articles by Pirofski, L. in: JCI | PubMed | Google Scholar

Published February 23, 2021 - More info

J Clin Invest. https://doi.org/10.1172/JCI148832.
Copyright © 2021, American Society for Clinical Investigation
Published February 23, 2021 - Version history
View PDF
Abstract

In recent months genomic characterization of pandemic SARS-CoV-2 isolates identified viral variants that are less susceptible to neutralization by convalescent plasma (CP), vaccine-elicited plasma/sera, or SARS-CoV-2 monoclonal antibodies than earlier SARS-CoV-2 strains. In this Viewpoint, Casadevall et al. argue against the causal association made in some press articles between the emergence of SARS-CoV-2 variants and convalescent plasma use.

Version history
  • Version 1 (February 23, 2021): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI

Related posts

  • COVID-19 article collection

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts